Pixuvri approved for use in EU
The drug has been granted the conversion of the conditional approval into standard marketing authorisation as a single agent.
Read More
Tag: non-Hodgkin B-cell lymphoma
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
